Abstract:Objective:To investigate the effect of endovascular treatment on acute ischemic stroke progression in posterior circulation (AISPPC) caused by large vessel stenosis or occlusions, and to provide evidence for the treatment strategy of AISPPC.Methods:According to the inclusion and exclusion criteria, 34 patients with AISPPC hospitalized in the Second Affiliated Hospital of Nanchang University from May 2020 to December 2021 were enrolled. Among them, 21 patients who were given vascular intervention plus standard drug therapy at the duration of progression were included in the observation group. Patients treated with aspirin plus Clopidogrel/Tirofiban/Argatroban were included in the control group (13 patients, one of whom was lost to follow-up). The preoperative data of the two groups were collected, including age, gender, past medical history, history of alcohol and tobacco use, etiology of cerebral infarction, imaging data, and National Institutes of Health stroke scale (NIHSS) score at onset and at exacerbation, incidence and complications of symptomatic intracranial hemorrhage (sICH). NIHSS score, modified Rankin scale (mRS) score, and mortality at 90 days after treatment were analyzed.Results:There were no significant differences in baseline characteristics between the two groups, such as age, gender, past medical history, history of alcohol and tobacco use, NIHSS score at onset and exacerbation, cause of cerebral infarction, posterior circulation acute stroke prognosis early computed tomography score (pcASPECTS) score, Bern (diffusion weighted imaging, DWI) score, and different responsible vessels (P＞0.05). Multiple logistic regression and linear regression analysis showed that, after adjusting age and gender, the 90-day mRS 0-2 score in the observation group was higher than that in the control group (76.19% vs 41.67%, P=0.039), and the 90-day mRS score was lower than that in the control group [1.00 (0, 2.00) vs 4.50 (1.75, 6.00)]. Multivariate logistic regression analysis showed that compared with the control group, the observation group had lower mortality, and the difference was statistically significant (14.29% vs 50.00%, OR=0.17, 95%CI: 0.03-0.88, P=0.035). Patients in both groups were followed up to 90 days. Among 21 patients in the observation group, 3 died (2 due to higher NIHSS scores during exacerbation and 1 due to bleeding transformation after reperfusion injury). Among 13 patients in the control group, one was lost to follow-up (at 14 days of follow-up), and 6 died (4 due to higher NIHSS scores during exacerbation and 2 patients died of severe complications). For the prognosis of the follow-up patients, K-M survival curve analysis showed that with the extension of follow-up time, the survival rate of the observation group was higher than that of the control group, and the risk of long-term recurrent cerebral infarction was reduced, and the difference was statistically significant (P＜0.05).Conclusion:Compared with conservative treatment, endovascular interventional therapy for AISPPC patients caused by large vessel stenosis or occlusions has better neurological function recovery and lower mortality, and dosen't increase the risk of sICH. Delayed vascularization still has a good therapeutic effect. In addition, randomized clinical trials are needed to evaluate its effectiveness.

Effect of “Drip-and-ship” and “Drip-and-drive” on Endovascular Treatment of Acute Ischemic Stroke with Large Vessel Occlusion: a Single-Center Retrospective Study

The Safety and Efficacy of Endovascular Treatment in Acute Ischemic Stroke Patients Caused by Large-Vessel Occlusion with Different Etiologies of Stroke: Data from ANGEL-ACT Registry

Prehospital Notification Procedure Improves Endovascular Treatment Outcome in Patients with Acute Ischemic Stroke

Clinical outcomes after endovascular thrombectomy in different triage methods

Endovascular Treatment for Minor Acute Ischemic Strokes with Large Vessel Occlusion

Silver Sulphadiazine and the Healing of Partial Thickness Burns: a Prospective Clinical Trial

Drip and Ship versus Mothership Model in the Middle Cerebral Artery Stroke: A Propensity-Matched Real-World Analysis Through National Inpatient Sample Data

Comparison between "Mothership" and "Drip and Ship" models in the management of acute ischemic strokes eligible for mechanical thrombectomy in the Charleroi area, Belgium

Influences of Different Referral Modes on Clinical Outcomes after Endovascular Therapy for Acute Ischemic Stroke

Thrombectomy: Comparison Between The Single And Dual Stentriever Techniques

Comparison of clinical outcomes in patients with acute ischemic stroke who underwent endovascular treatment using different perfusion modalities: a real-world multicenter study

Endovascular treatment over 24 hours after ischemic stroke onset: a single-center retrospective study

Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct

Effect of endovascular treatment on acute progressive ischemic stroke in posterior circulation

Effect of time delay in inter-hospital transfer on outcomes of endovascular treatment of acute ischemic stroke

Endovascular therapy for acute ischemic stroke with distal medium vessel occlusion: a systematic review and meta-analysis

Endovascular Versus Medical Management in Distal Medium Vessel Occlusion Stroke: The DUSK Study

Endovascular therapy versus medical management in isolated posterior cerebral artery acute ischemic stroke: A multinational multicenter propensity score-weighted study

Endovascular Treatment with and Without Intravenous Thrombolysis in Large Vessel Occlusions Stroke: A Systematic Review and Meta-Analysis

Endovascular Therapy for Acute Ischemic Stroke in Patients with Large-Vessel Occlusion due to Atherosclerotic Stenosis

EMS Bypass to Endovascular Stroke Centers is Associated with Shorter Time to Thrombolysis and Thrombectomy for LVO Stroke